News
Company whistleblower program part of Ranbaxy consent decree
www.fiercepharmamanufacturing.com
[FiercePharma Manufacturing] - But as Ravi Ananthanarayanan points out in an article on livemint.com, for another four FTF drugs it has to comply with data submission and audit requirements by certain dates or lose exclusivity for those as well. A review of the consent degree to
Catastrophic failure, but how? - Times of India
timesofindia.indiatimes.com
World News: HONG KONG: Two stark facts …te speculation concerning the sudden crash of a China Airlines Boeing on Saturday afternoon.
GSK's growing cash burden - WSJ
www.wsj.com
Indian pharma company GlaxoSmithKline is sitting on a pot of cash and not doing much with it, not even looking for acquisitions or investing in factories,...
Ravi Ananthanarayanan & Anto Joseph: Advice by Market Experts,...
economictimes.indiatimes.com
Find the best market expert's advice, recommendation, ideas & news on stock, investment, issues of investor interest & more by Ravi Ananthanarayanan & Anto...
sorted by relevance / date